Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
PTSD
About this trial
This is an interventional treatment trial for PTSD focused on measuring Prolonged Exposure for Primary Care, Mobile device, Clinician Supported PTSD Coach App, PTSD symptoms, Prolonged Exposure/PE
Eligibility Criteria
Inclusion Criteria:
- Receive care at a participating Michigan federally qualified community health center (FQHC)
- Have a Posttraumatic Stress Disorder checklist (PCL-5) score greater or equal (≥) to 33
- Own a mobile device that can be used for the PTSD Coach App
- Have had psychotropic medication stability for at least 4 weeks
Exclusion Criteria:
- Severe cognitive impairment that in the judgment of the investigators makes it unlikely that the participant can adhere to the study regimen (as evidenced by confusion, inability to track discussion or answer questions, or other clear and significant indicators of cognitive impairment)
- High risk of suicide (defined as meeting criteria for Action Step 3 on the Participant Suicide Risk Screening form
- Severe alcohol or substance use disorder (moderate-severe alcohol use disorder on Alcohol Use Disorders Identification Test (AUDIT) (scores ≥ 15) or high risk on National Institute on Drug Abuse Quick Screen (scores ≥ 27))
- Active psychosis or unmanaged bipolar disorder
- Unstable housing
- Current engagement in a trauma-focused behavioral treatment (such as Prolonged Exposure or Cognitive Processing Therapy).
- Patients who do not speak English will be excluded for logistical reasons.
Sites / Locations
- Family Health Care
- Grace HealthRecruiting
- Hamilton Community Health NetworkRecruiting
- Cherry HealthRecruiting
- MidMichigan Community Health ServicesRecruiting
- Upper Great Lakes Family Health Care CenterRecruiting
- Family Medical Center of MichiganRecruiting
- Sterling Area Health CenterRecruiting
- Family Care Health CentersRecruiting
- Western North Carolina Community Health ServicesRecruiting
- CommUnityCare Health CentersRecruiting
- Unity Care NWRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Prolonged Exposure for Primary Care (PE-PC) then continue as early responder
Clinician Supported (CS) PTSD Coach App then continue as early responder
Prolonged Exposure for Primary Care (PE-PC) then full PE
Clinician Supported PTSD Coach App then full PE
Prolonged Exposure for Primary Care (PE-PC) then continued PE-PC
Clinician Supported PTSD Coach App then continued CS PTSD Coach App
PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), early responders will step down to every-other-week sessions for the duration of the second stage (for 8 weeks).
During the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first). Early responders will be encouraged to continue app use but will discontinue clinician support sessions for 8 weeks.
PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
During the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first), slow responders that are then randomized to full PE will have sessions once a week for eight weeks. During these 60 minute sessions, participants will practice in vivo and imaginal exposure and continue these exposure exercises every day at home.
PE-PC consists of four weekly 30-minute sessions. At the 4th session or 9-week assessment point (whichever comes first), slow responders that are then randomized to continue with PE-PC (medium intensity) will continue weekly sessions for 8 weeks.
During the first stage of treatment, participants will receive four weekly clinician support sessions or 9 weeks (whichever occurs first), slow responders that are then randomized to continue this treatment will have the frequency reduced to twice monthly.